FR-229934
FR-229934 is a PDE V inhibitor extracted from patent WO2019130052A1. FR-229934 can be used for the research of pulmonary arterial hypertension and erectile dysfunction[1].
Product Specifications
CAS Number
799841-02-4
UNSPSC
12352005
Target
Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/fr-229934.html
Purity
98.65
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=CC=C2N=C(C)N(CC3=CC=C(Cl)C(Cl)=C3)C2=C1)NS(=O)(CCCCC)=O
Molecular Formula
C21H23Cl2N3O3S
Molecular Weight
468.40
References & Citations
[1]PANDYA J, et, al. Liquid oral formulations for pde v inhibitors. WO2019130052A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PDE5
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY427299 100 µg
XPD (ERCC2) (NM_001130867) Human Over-expression Lysate
Sign In for Pricing
View Details 
